SQZ Biotechnologies Co:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:SQZ Biotechnologies Co - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10967
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
SQZ Biotechnologies Co (SQZ) develops cell-based therapies that harness the body’s natural immune system against cancer. The company utilizes CellSqueeze, a technology platform for engineering various cell functions as antigen presenting cells (APCs) for immune modulation to impact oncology and autoimmune disease applications. SQZ’s APC approach enables delivery of cancer-specific antigens to the cytosol of the APC which generates polyclonal T cell responses. The company works in partnership with other academic institutions, pharmaceutical and biotechnology companies focusing on developing new cell therapies and approaches for that transform patient lives. SQZ is headquartered in Watertown, Massachusetts, the US.

SQZ Biotechnologies Co – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
SQZ Biotechnologies Co, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SQZ Biotechnologies Co, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SQZ Biotechnologies Co, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SQZ Biotechnologies Co, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
SQZ Biotechnologies Co, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
SQZ Biotechnologies Co, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
SQZ Biotech Raises USD72 Million in Series C Financing 10
SQZ Biotech Raises Funds through Venture Financing 12
SQZ Biotech Raises Additional USD4 Million in Series B Financing 13
SQZ Biotech Raises USD16 Million in Series B Financing 14
SQZ Biotech Raises USD5 Million in Series A Venture Financing 15
SQZ Biotechnologies Raises Funds through Venture Financing 16
Partnerships 17
Roche Expands Agreement with SQZ Biotech 17
Licensing Agreements 18
SQZ Biotec Enters into License Agreement with Massachusetts Institute of Technology 18
SQZ Biotechnologies Co – Key Competitors 19
SQZ Biotechnologies Co – Key Employees 20
SQZ Biotechnologies Co – Locations And Subsidiaries 21
Head Office 21
Recent Developments 22
Corporate Communications 22
Sep 27, 2018: SQZ Biotech Announces Key Executive and Board of Directors Appointments 22
Aug 23, 2017: SQZ Biotech Expands Leadership Team, Appoints Shefali Agarwal, MD, MPH, as Chief Medical Officer 23
Other Significant Developments 24
May 14, 2018: SQZ Biotech CEO to Participate in BIO International Panel and to Present at Investor Conferences in Second Quarter 2018 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
SQZ Biotechnologies Co, Pharmaceuticals & Healthcare, Key Facts 2
SQZ Biotechnologies Co, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SQZ Biotechnologies Co, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SQZ Biotechnologies Co, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SQZ Biotechnologies Co, Deals By Therapy Area, 2012 to YTD 2018 8
SQZ Biotechnologies Co, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
SQZ Biotech Raises USD72 Million in Series C Financing 10
SQZ Biotech Raises Funds through Venture Financing 12
SQZ Biotech Raises Additional USD4 Million in Series B Financing 13
SQZ Biotech Raises USD16 Million in Series B Financing 14
SQZ Biotech Raises USD5 Million in Series A Venture Financing 15
SQZ Biotechnologies Raises Funds through Venture Financing 16
Roche Expands Agreement with SQZ Biotech 17
SQZ Biotec Enters into License Agreement with Massachusetts Institute of Technology 18
SQZ Biotechnologies Co, Key Competitors 19
SQZ Biotechnologies Co, Key Employees 20

List of Figures
SQZ Biotechnologies Co, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
SQZ Biotechnologies Co, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
SQZ Biotechnologies Co, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
SQZ Biotechnologies Co, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
SQZ Biotechnologies Co, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SQZ Biotechnologies Co, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
SQZ Biotechnologies Co, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SQZ Biotechnologies Co, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[SQZ Biotechnologies Co:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Finder Exploration Pty Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Finder Exploration Pty Ltd (Finder) is an oil and gas company that acquires and explores prospective acreage. The company offers acquisition of prospective acreage through drilling and detailed assessment and risk mitigation of exploration acreage. It holds exploration operations in Bedout S …
  • National HealthCare Corp (NHC):企業の財務・戦略的SWOT分析
    Summary National HealthCare Corp (NHC) is a health care service provider that offers home-care and assisted living services. The center offers rehabilitative care, skilled nursing care, Alzheimer's and memory care, residential and assisted living, home care, hospice care and long term care insurance …
  • Baumot Group AG (TINC):企業の財務・戦略的SWOT分析
    Baumot Group AG (TINC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Cedars-Sinai Medical Center-医療機器分野:企業M&A・提携分析
    Summary Cedars-Sinai Medical Center (Cedars-Sinai), formerly Kaspare Cohn Hospital is an academic and medical center that provides healthcare services for patients and medical professionals, and research and education services. The center offers treatments for various conditions such as abdominal pa …
  • Al Salam Bank BSC (SALAM):企業の財務・戦略的SWOT分析
    Al Salam Bank BSC (SALAM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Billabong International Limited:企業のM&A・事業提携・投資動向
    Billabong International Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Billabong International Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Fluor Corp (FLR):石油・ガス:M&Aディール及び事業提携情報
    Summary Fluor Corp (Fluor) is a provider of engineering and construction services. The company's service portfolio includes design, engineering, procurement, fabrication, modularization, construction, commissioning and maintenance, and project management solutions. Fluor also offers other services t …
  • Syros Pharmaceuticals Inc (SYRS):医療機器:M&Aディール及び事業提携情報
    Summary Syros Pharmaceuticals Inc (Syros) is a biopharmaceutical company that develops medicines for the treatment of cancer, immune-mediated diseases, and other diseases. The company’s pipeline products under clinical trials include SY-1425, an oral, potent and selective RARa agonist that is used t …
  • Amplifon SpA (AMP):企業の財務・戦略的SWOT分析
    Amplifon SpA (AMP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Triangle Capital Corp:企業のM&A・事業提携・投資動向
    Triangle Capital Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Triangle Capital Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • University of Pittsburgh Medical Center:医療機器:M&Aディール及び事業提携情報
    Summary University of Pittsburgh Medical Center (UPMC) is a health care provider organization. It is a non-profit health care firm comprising a wide network of hospitals, clinics, and long-term care, rehabilitation and retirement facilities. The company offers several services such as commercial, me …
  • PJSC Detsky Mir (DSKY):企業の財務・戦略的SWOT分析
    PJSC Detsky Mir (DSKY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • SARomics Biostructures AB:製薬・医療:M&Aディール及び事業提携情報
    Summary SARomics Biostructures AB (Saromics) is a contract research organization that offers structural biology and drug discovery outsourcing services platform for biotech and pharmaceutical companies. The organization provides services in protein crystallization, protein crystallography, protein N …
  • Nanobiotix SA (NANO):企業の財務・戦略的SWOT分析
    Summary Nanobiotix SA (Nanobiotix) designs and manufactures nanomedicines for the treatment of cancer. The company is evaluating its lead product candidate NBTXR3 against soft tissue sarcoma, pancreatic, liver, rectal, prostate, head and neck cancers; Non-small cell lung cancer (NSCLC); recurrent he …
  • OK Biotech Co Ltd (4155):医療機器:M&Aディール及び事業提携情報
    Summary OK Biotech Co Ltd (OK Biotech) is a medical device manufacturing and distribution company that manufactures and distributes blood glucose monitoring devices and homecare medical products, among others. The company’s blood glucose monitoring devices include blood glucose meter systems, blood …
  • Och-Ziff Capital Management Group LLC (OZM):企業の財務・戦略的SWOT分析
    Summary Och-Ziff Capital Management Group LLC (Oz Management) is an alternative asset management firm that provides asset management services. The firm’s services portfolio includes portfolio management, private investments, funds management, and equity funds investment and management services. Its …
  • DURECT Corp (DRRX):企業の財務・戦略的SWOT分析
    DURECT Corp (DRRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Fresenius Medical Care AG & Co. KGaA:企業の戦略・SWOT・財務分析
    Fresenius Medical Care AG & Co. KGaA - Strategy, SWOT and Corporate Finance Report Summary Fresenius Medical Care AG & Co. KGaA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Concord New Energy Group Ltd (182):企業の財務・戦略的SWOT分析
    Concord New Energy Group Ltd (182) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Encompass Health Corp (HLS):製薬・医療:M&Aディール及び事業提携情報
    Summary Encompass Health Corp (Encompass Health), formerly HealthSouth Corp is a post-acute healthcare service provider that offers rehabilitation and home based patient care services. The center owns and operates inpatient rehabilitation and hospitals and provides treatment to medical conditions su …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆